Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,401–2,500 of 3,349
Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer’s disease
Fan, X., Wang, H., Ping, J., Li, M., Gu, J., & Qian, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117401 · Cited by 15
Zhang, Q., Lo, H., Song, Y., Feng, L., You, H., Chen, X., Wang, Y., & Pan, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03598-8 · Cited by 4
“Multiple studies have indicated that activated microglia can release diverse in fl ammatory mediators, such as complement, cytokines, and chemokines, contributing to the impairment of neurons and synapses in AD [22, 23].”
Polu, P. R., & Mishra, S. (2025) · Journal of Neurogenetics · doi:10.1080/01677063.2025.2571127 · Cited by 5
“Complement proteins C1q, C3, and C4 are upregulated in aging brains and mark synapses for elimination by microglia, with genetic variants in complement genes showing associations with cognitive aging and Alzheimer’s disease risk (Hong et al. , 2016; Shi et al. , 2015).”
LRRK2 and the fragile synapse: a molecular prelude to Parkinson’s disease?
Masotti, B., Tombesi, G., Parisiadou, L., & Greggio, E. (2025) · Biochemical Journal · doi:10.1042/bcj20253351 · Cited by 8
“Microglia and, to a lesser extent, astrocytes are responsible for the phagocytic removal of compromised synapses [36,37], a process that, if dysregulated, could aggravate synaptic loss and neuronal damage [13].”
The transcriptional and cellular landscape of cognitive resilience to Alzheimer’s disease
Khera, N., Raju, R. M., & Lipton, S. A. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1665802 · Cited by 3
Vigo, T., Mariani, M. C., Bason, C., Ferrara, G. B., Cornacchia, E., Francia, S., Potenzieri, A., Ricci, E., Grasselli, G., Zoppoli, G. M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116556 · Cited by 4
He, D., Guo, S.-Y., Yang, Y.-C., Wang, H., Zhang, Y., Mo, X., Liu, L., Qin, Z., & Xie, P. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03761-1 · Cited by 6
“These fi ndings demonstrate that NADPH preserves existing myelin and synaptic integrity in parallel with its antidepressant-like effects, and crucially, microglial activity is essential for these neurorestorative processes.”
Liu, C., Xu, S., Yao, H., Wang, Y., Liu, Q., Zhou, H., Luo, Y., Li, X., Li, S., & Li, Q. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03644-8 · Cited by 7
“Specifically, SerpinA3N knockdown attenuated AD-associated neuro-inflammation by normalizing levels of pro-inflammatory cytokines (Il1β, Il6, TNF-α, and iNOS) in hippocampus and reducing secretion of the neurotoxic factor C3, a known mediator of microglia-dependent synapse loss [54].”
Self-citationSilva, A. L. T. E., de Oliveira, P. H. P., Yokota-Moreno, B. Y., Fausto, J. D. S., Avila, J. P., Nakaya, H. I., Sertie, A. L., & Zampieri, B. L. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02090-0 · Cited by 6
Liu, R., Yan, H., Liu, X., Xie, Y., Li, Y., Wang, Z., Huang, H., Yu, Z., Qu, W., Wang, M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03661-7 · Cited by 7
“Under pathological conditions, synapse clearance by microglia is typically mediated by the classical complement cascade, with complement components C1q and C3 playing critical roles in tagging damaged synapses [53–55].”
He, J., Han, X., Tan, Y.-S., Yao, Z., Dong, Y.-L., & Feng, C. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03651-9 · Cited by 5
“Activated microglia release cytokines, reactive oxygen species (ROS), and adhesion molecules [40], which exacerbate axonal/synaptic damage, promote demyelination, and impair white matter integrity across multiple brain regions [41].”
Jian-Da, L., Li, H., Hsu, C., Lin, T.-L., Chuang, H.-L., Lin, H.-I., Ho, E.-P., Chen, Y.-H., Liu, C.-W., Chuang, Y.-T., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.12.028 · Cited by 4
“Given that synaptic dysfunction represen ts an early hallmark of neuroinflammation in disorders such as multiple sclerosis and Alzheimer’s disease (AD) [53,54], this mechanism may contribute to restraining glial activation.”
Yang, Y., Liu, X., Wang, H., Wen, H., Zhong, J., Zhang, W., Xian, Y., Wang, Y., Qin, G., Zhang, D., et al. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02229-3 · Cited by 4
“Normally, moderate pruning enhances brain network efficiency by eliminating unnecessary connections [9–12]; however, excessive pruning is associated with cognitive disorders, like Alzheimer’s disease and frontotemporal dementia [13–15].”
Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Takahashi, T., & Muguruma, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062357 · Cited by 4
The complement system in Alzheimer’s disease: mechanisms, biomarkers, and therapeutic implications
Liu, G., Deng, B., Han, X., Zhao, Y. C., Zeng, S., Yu, S., Wang, L., Wang, S., Wu, Y. J., Cai, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1798288 · Cited by 5
“Neuropathological investigations further reveal pronounced activation of the classical complement cascade (C1q – C3 – MAC) in the vicinity of A b plaques and tau tangles, a process closely associated with aberrant synaptic pruning and microglia-mediated neurotoxicity (7 – 9).”
InfluentialDysfunction of the neurovascular unit as a temporal driver in Alzheimer’s pathogenesis
Wang, L., Han, L., & Liu, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00548-2 · Cited by 7
“The disease-associated microglia (DAM) phenotype, a unique microglial state implicated in restricting AD pathology [81], is highly distributed in the AD hippocampus, particularly in the fimbria region, with elevated expression of complement system-related genes C3 and C1QB [77, 82].”
Lu, X., Jiang, Y., Lin, X., Zhang, Y. X., Liu, Q., & Chen, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03866-4 · Cited by 3
“Given the established role of the complement cascade and S100A10 in pathological synapse elimination, this suppression of C3 and the upregulation of S100A10 provide a plausible mechanistic link between glial modulation and the observed preservation of synaptic proteins [64, 65].”
Pathological Roles of INPP5D in Alzheimer’s Disease
Chu, Y. N., Akahori, A., Takatori, S., & Tomita, T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31978-5_30 · Cited by 4
Chakraborty, S., & Sinha, A. (2023) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v11i4.1302 · Cited by 4
“Research concludes that A1 astrocytes in a mouse model increase the release rate of an unknown neurotoxin, causing neuronal death and decreasing neuronal survival and synapse formation (43) .”
BackgroundFu, X., Wang, M., Wan, Y., Hua, Y., Keep, R. F., & Xi, G. (2024) · Biomedicines · doi:10.3390/biomedicines12061251 · Cited by 4
“In Alzheimer’s disease, the inhibition of C3 has been linked to a reduction in the number of phagocytic microglia [15].”
BackgroundGutierrez, J., Kurz, C., Sandoval, C., Edmonds, R., Bittner, T., Perneczky, R., & Biever, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240287 · Cited by 3
Effects of aging on diurnal transcriptome change in the mouse corpus callosum
Ishikawa, H., Hoshino, T., Hamanaka, G., Mandeville, E. T., Guo, S., Kimura, S., Fukuda, N., Li, W., Shindo, A., Sakadžić, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111556 · Cited by 3
“60,61 Therefore, the persistent upregulation of complement pathway genes may indicate a chronic inflammatory response or dysregulation associated with aging, which would contribute to age-related cognitive decline and neurodegenerative processes.”
Regulation of presynaptic homeostatic plasticity by glial signalling in Alzheimer's disease
Cai, Y., & Wang, T. (2024) · The Journal of Physiology · doi:10.1113/jp286751 · Cited by 4
“In AD, various glial types, including astrocytes, microglia and oligodendrocytes, exert a significant influence on neuronal function (Blanchard et al., 2022; Hong et al., 2016; McAlpine et al., 2021; Shah et al., 2022).”
Shi, J., Zhang, M., Hu, Y., Liu, J., Li, K., Sun, X., Chen, S., Liu, J., Ye, L., Fan, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106909 · Cited by 4
“Microglia regulate the extent of amyloid deposition through phagocytosis (Lee and Landreth, 2010; Morgan, 2009), but under pathological conditions, they may also phagocytose synapses (Shi et al., 2017; Hong et al., 2016).”
Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches
Lim, D. X. E., Yeo, S. Y., Chia, Z. Y. A., Fernandis, A. Z., Lee, J., & Chua, J. J. E. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01375 · Cited by 14
Neuro-immune interactions in memory
Stewart, E., & Ryan, T. J. (2025) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2025.108077 · Cited by 4
“Inhibition of complement proteins C1q, C3 or microglial complement receptor CR3 reduces the extent of early synapse loss in mouse models of Alzheimer’s Disease suggesting aberrant removal of synapses may result in amnesia (Hong et al. , 2016).”
Chen, H., Cao, J., Zhang, Y., Su, X., Kang, Y., Gao, L., & Jing, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202501545rr · Cited by 4
“Pathological accumulation of Aβ or Tau at the synapse leads to the upregulation of C1q in perisynaptic microglia, which then binds to complement receptors on the synapse, ultimately initiating synaptic endocytosis in microglia [18–20].”
Krunic, A., Bellio, T. A., Cohen, B. Z., Labadorf, A. T., Stein, T. D., Lin, H., Mellott, T. J., & Blusztajn, J. K. (2025) · Aging Cell · doi:10.1111/acel.70241 · Cited by 7
“However, it is also involved in synapse elimination and has been implicated in synapse loss and neuropathology in AD mouse models (Dejanovic et al. 2022; Fonseca et al. 2004; Hong et al. 2016).”
Ding, Y., Li, M., Ding, P., Wang, P., & Guan, P.-P. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c04420 · Cited by 5
Xiao, L., Sharma, P., Yang, X., Abebe, D. T., & Loh, Y. P. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00520-6 · Cited by 4
“Consistently, decreased synaptic density and activity have also been observed in AD mouse models [34, 35].”
APP Modulates Aβ-Induced Activation of Microglia in Mouse Model of Alzheimer's Disease
Datta, D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3122-16.2017 · Cited by 3
“…that complement cascade signaling and microglial activation mediate early synapse loss and neurite dysfunction in AD mouse models and that aberrant reactivation of developmental synaptic pruning pathways might drive the pathogenesis of the illness (Kettenmann et al., 2013; Hong et al., 2016).”
BackgroundPerivascular signals drive microglial appetite
O’Brien, C. A., & Bennett, F. C. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01256-0 · Cited by 3
Datta, D. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad134 · Cited by 4
Delgardo, M. W., Tang, A. J., Tudor, T., Pascual-Leone, A., & Connolly, E. S. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1123365 · Cited by 4
“Moreover, C1q, which binds to gC1qR, has been shown to bind to amyloid-beta (AB) peptide, which is a major component of the senile plaques in AD, and the binding of C1q to AB may trigger the complement cascade, resulting in inflammation and synaptic loss (Rogers et al., 1992; Hong et al., 2016).”
BackgroundCleaning crew: Soluble TREM2 mops up complement
Monroe, K. M., & Lewcock, J. W. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.012 · Cited by 3
K252a Prevents Microglial Activation Induced by Anoxic Stimulation of Carotid Bodies in Rats
Cuéllar-Pérez, R., Jáuregui-Huerta, F., Ruvalcaba-Delgadillo, Y., Montero, S., Lemus, M., de Álvarez-Buylla, E. R., García‐Estrada, J., & Luquín, S. (2023) · Toxics · doi:10.3390/toxics11100871 · Cited by 4
“The activation of microglia is a double-edged sword, as it is essential for clearing damaged cells and debris from the brain [16] but can also lead to neuroinflammation and neurode-generation [17,18].”
BackgroundDey, K. K., Yarbro, J. M., Liu, D., Han, X., Wang, Z., Jiao, Y., Wu, Z., Yang, S., Lee, D. G., Dasgupta, A., et al. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00496 · Cited by 2
Hazi, A., Ebrahimie, E., Levay, E. A., Dehcheshmeh, M. M., Zelko, M. D., Govic, A., & Nasser, H. M. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1257881 · Cited by 4
“…expression, a gene with documented links with anxiety-like behavior (Bai et al., 2022; Maras et al., 2022), ostensibly through its role in inflammation, and Alzheimer’s disease, through its role in synapse elimination and neuronal damage (Hong et al., 2016; Dejanovic et al., 2018; Wu et al., 2019).”
BackgroundSeicol, B. J., Guo, Z., Garrity, K., & Xie, R. (2023) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2023.1294525 · Cited by 4
“Reactivation of these developmental functions may contribute to age-related diseases, such as Alzheimer’s disease (Hong et al., 2016).”
BackgroundBollinger, J. L., Horchar, M. J., & Wohleb, E. S. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001759 · Cited by 3
Immune receptors and aging brain
Djurisic, M. R. (2024) · Bioscience Reports · doi:10.1042/bsr20222267 · Cited by 3
“Finally, synaptic material tagged with cleavage products of C3 was engulfed by microglia in a CR3-dependent manner upon exposure to oligomeric A β [68].”
BackgroundInfluentialNeuron mapping in the Molly fish optic tectum: An emphasis on the adult neurogenesis process
Hussein, M. T., Sayed, R. K. A., & Mokhtar, D. M. (2024) · Microscopy Research and Technique · doi:10.1002/jemt.24617 · Cited by 3
“Microglia are recognized as key modulators in neuronal development and plasticity, providing support to brain tissue (Hong et al., 2016; Tremblay et al., 2010).”
Elucidation of the role of microglia‐macrophage‐based neuroinflammation in neurological diseases
Yamasaki, R. (2024) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12829 · Cited by 3
“26 Similarly, astrocyte–microglia interactions modulated the astrocytic release of neurotrophic factors and uptake of neurotransmitters, further influencing neuronal activity and CNS homeostasis.”
Zou, C., Cai, R., Li, Y., Yu, X., Zhang, G., Alitongbieke, G., Pan, Y., & Zhang, S. Q. (2024) · iScience · doi:10.1016/j.isci.2024.110766 · Cited by 3
Mey, G. M., Evonuk, K. S., Shelestak, J., Irfan, M., Wolfe, L. M., Laye, S. E., Schafer, D. P., & DeSilva, T. M. (2024) · iScience · doi:10.1016/j.isci.2024.111226 · Cited by 3
“Excitatory synapticpruningisregulatedbycomplementindevelopmentand disease 2,35,36 andsynapticlossin thedLGNisassociatedwith complementfactorC3depositioninEAE.”
Xia, T., Yan, Z., Shen, P., Chang, M., Zhang, N., Zhang, Y., Chen, Q., Wang, R., Tong, L., Zhou, W. J., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18050738 · Cited by 3
“For example, in Alzheimer’s disease (AD), the aberrant accumulation of β -amyloid specifically activates intracellular inflammasomes, contributing to the overproduction of the pro-inflammatory factors IL-1 β and TNF-α , which impair synaptic signaling efficiency [29].”
Formyl peptide receptor 2 antagonist WRW4 ameliorates diabetes-induced cognitive decline in mice
Uno, H., Itokazu, T., & Yamashita, T. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104932 · Cited by 3
“The aggravation of phagocytic activity in the microglia is known to disrupt synaptic refinement and maintenance, impairing the fundamental function of the hippocampus (Crapser et al., 2021; Hong et al., 2016).”
Quantifying miRNA Deregulation in Alzheimer’s Disease
Cardoso, A. L., & Guedes, J. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_21 · Cited by 4
Adenosine Receptors and Neuroinflammation
Ferrante, A., Simone, R. D., Ajmone‐Cat, M. A., Minghetti, L., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_9 · Cited by 6
DeKorver, N. W., Chaudoin, T. R., Zhao, G., Wang, D., Arikkath, J., & Bonasera, S. J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02480-0 · Cited by 3
Acharjee, S., & Pittman, Q. J. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519825882 · Cited by 3
Role of Agmatine on Neuroglia in Central Nervous System Injury
Barua, S., Kim, J. Y., & Lee, J. E. (2019) · Brain & Neurorehabilitation · doi:10.12786/bn.2019.12.e2 · Cited by 4
“In AD, frontotemporal dementia, normal aging, axonal pruning has been reported to be associated with an increase in microglial expression of C1q, accompanied by compliment component C3 [55-57].”
BackgroundPiper, J.-E. (1999) · Cited by 4
Translational profiling of microglia reveals artifacts of cell sortingPreprint
Kang, S. S., Baker, K. E., Wang, X., Kocher, J.-P., & Fryer, J. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/135566 · Cited by 5
“…survey the CNS milieu and participate in synaptic pruning and shaping of neuronal circuits during homeostatic and inflammatory conditions (Hong et al., 2016a, 2016b; Lawson et al., 1990; Miyamoto et al., 2013, 2016; Nimmerjahn et al., 2005; Paolicelli et al., 2011; Schafer et al., 2012,…”
BackgroundWNT vampirization by glioblastoma leads to tumor growth and neurodegenerationPreprint
Portela, M., Venkataramani, V., Fahey-Lozano, N., Seco, E., Losada‐Pérez, M., Winkler, F., & Casas‐Tintó, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/428953 · Cited by 3
Madore, C., Leyrolle, Q., Morel, L., Delpech, J.-C., Greenhalgh, A. D., Lacabanne, C., Bosch‐Bouju, C., Bourel, J., Thomazeau, A., Hopperton, K. E., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/744136 · Cited by 3
McGann, J. C., Spinner, M. A., Garg†, S. K., Müllendorff, K., Woltjer, R. L., & Mandel, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.07.192229 · Cited by 2
“However, increased levels of C1Q protein results in AD synapse pathology [63], and this gene induction is compatible with the reduction of REST binding that occurs with AD [21].”
BackgroundThe Sez6 family inhibits complement at the level of the C3 convertasePreprint
Qiu, W., Luo, S., Ma, S. A., Saminathan, P., Li, H., Gunnersen, J. M., Gelbard, H. A., & Hammond, J. W. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.11.292623 · Cited by 3
“frontotemporal dementia, and multiple sclerosis [33-35, 39-52].”
Abi3 regulates microglial ramification and dynamic tissue surveillance in vivo
Simonazzi, E., Jones, R. E., Chen, F., Ranson, A., Stevenson-Hoare, J., Escott-Price, V., Sengpiel, F., Morgan, B. P., & Taylor, P. R. (2021) · doi:10.1101/2021.03.19.436147 · Cited by 3
Chen, S., Chang, Y., Li, L., Acosta, D. M., Morrison, C. T., Wang, C., Julian, D. L., Hester, M. E., Serrano, G. E., Beach, T. G., et al. (2021) · SSRN Electronic Journal · doi:10.21203/rs.3.rs-855234/v1 · Cited by 4
Distinct effects of disease-associated TREM2 R47H/+ and T66M mutations on iPSC-derived microgliaPreprint
Penney, J., Ralvenius, W. T., Loon, A. R., Cerit, O., Dileep, V., Milo, B., Woolf, H., & Tsai, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.05.511003 · Cited by 3
“TREM2 has been shown to play a role in developmental synaptic pruning in the mouse brain, and microglia have also been demonstrated to engage in inappropriate synaptic pruning in adult Alzheimer’s disease mice (Filipello et al., 2018; Hong et al., 2016; Salter and Stevens, 2017).”
BackgroundMicroglia-mediated neurovascular unit dysfunction in Alzheimer’s diseasePreprint
Huang, W., Xia, Q., Zheng, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2125970/v1 · Cited by 3
Ulbrich, P., Morton, L., Briese, M., Lämmlin, N., Mattern, H., Hasanuzzaman, M., Westhues, M., Khoshneviszadeh, M., Appenzeller, S., Gündel, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.20.524921 · Cited by 3
Changes to Astrocyte-associated Protein Expression at Different Timepoints of Cuprizone TreatmentPreprint
Frankle, L., Riley, A., Tomor, R., Lee, H., Jarzembak, K., Benedict, O., Sternbach, S., Shelestak, J., McDonough, J. A., & Clements, R. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.20.537627 · Cited by 3
Heuer, S. E., Keezer, K. J., Hewes, A. A., Onos, K. D., Graham, K. C., Howell, G. R., & Bloss, E. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.28.538728 · Cited by 3
Gharibani, P. M., Abramson, E., Shanmukha, S., Smith, M. D., Godfrey, W. H., Lee, J. J., Hu, J., Baydyuk, M., Dorion, M., Deng, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.28.555084 · Cited by 3
“C3 directly contributes to the neuronal loss in both inflammatory and neurodegenerative contexts (13, 41, 42, 44), and C3 genetic variants have been linked to faster rates of neurodegeneration in MS (43).”
Mackie, P. M., Koshy, J., Bhogade, M., Hammoor, T., Hachmeister, W., Lloyd, G. M., Paterno, G., Bolen, M. L., Tansey, M. G., Giasson, B. I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563832 · Cited by 3
Cell autonomous microglia defects in a stem cell model of frontotemporal dementiaPreprint
Iyer, A. K., Vermunt, L., Mirfakhar, F. S., Minaya, M., Acquarone, M., Koppisetti, R. K., Renganathan, A., You, S., Danhash, E., Verbeck, A. C., et al. (2024) · medRxiv · doi:10.1101/2024.05.15.24307444 · Cited by 3
“Impaired microglia-mediated clearance of phagocytosed tau can lead to propagation of tau pathology through secretion and promote a vicious cycle that may drive pathological decline 10, 25, 29, 30 .”
BackgroundRao, N. R., DeGulis, O. A., Nomura, T., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E. X., Dulewicz, M., Ge, J., Upadhyay, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620698 · Cited by 3
Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampusPreprint
Nguyen, V. D., Bright, M., Zhou, Y., Morgan, B. P., & Zelek, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652374 · Cited by 3
Wang, Y., Pandey, S., Weber, M., Choy, M. K., Wu, T. Z., Chernov-Rogan, T., Ngu, H., Foreman, O., Xie, L., & Hanson, J. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.16.660026 · Cited by 3
Lane-Donovan, C., Paredes, M., & Kao, A. W. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102854 · Cited by 3
Wang, F., Cai, Y., Ma, X., Wang, N., Wu, Z., Sun, Y., Xu, Y., Yang, H., Liu, T., Qin, X., et al. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00710-2 · Cited by 3
“Digital images at 20,000× (15 images per animal) were used to evaluate postsynaptic density (PSD) juxtaposed with presynaptic bouton-containing vesicles [36, 37].”
BackgroundMethodSun, S., Luo, S., Chen, J., Zhang, O., Wu, Q., Zeng, N., Bi, J., Zheng, C., Yan, T., Li, Z., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1431689 · Cited by 5
“This suggests that hUC-MSCs may be bene fi cial in treating conditions with immune dysfunction including ASD (13).”
BackgroundMethodYoshioka, M., Takahashi, M., Kershaw, J., Handa, M., Takada, A., & Takuwa, H. (2024) · Neurophotonics · doi:10.1117/1.nph.11.3.035009 · Cited by 5
“38,39 Zhang et al. 28 reported inflammatory microglial activation and subsequent white matter lesions after 1, 2, and 4 weeks of CCAO.”
BackgroundCastranio, E. L., Varghese, M., Argyrousi, E. K., Tripathi, K. K., Huang, Y., Asada, A., Söderberg, L., Bresnahan, E., Lerner, D., Garretti, F., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71426 · Cited by 2
Sun, C., Kang, X., Jia, X., Wang, Y., Zhao, L., Sun, X., Abula, A., & Liu, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052055 · Cited by 3
Huang, X., Zeng, J., Hu, Z., Wu, Y., Zhang, G., Zhang, C., Yu, C., & Song, M. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05109-8 · Cited by 2
“The resulting C3b and its degradation product, iC3b, are recognized by CR3 on the surface of microglia, which subsequently engage in synaptic pruning [32, 33].”
Mantovani, D. B. D. A., Oliveira, L. C., Spelta, L. E. W., Carvalho, C. L., Forlenza, O. V., Marie, S. K. N., Buchpiguel, C. A., Coutinho, A. M., & Faria, D. D. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70449 · Cited by 2
“34,35 In the present study, increased [ 11 C]PK11195 uptake was found in individuals with DS, with a substantial increase observed in individuals ≥ 50 years of age compared with non-DS age-matched individuals.”
Doshmanziari, M., Sarveazad, A., Moradi, F., Simorgh, S., Shariatpanahi, M., & Eftekharzadeh, M. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100285 · Cited by 4
Maruthiyodan, S., Munegowda, G., Thomas, M., Gangadharan, G., Joshi, M. B., Mumbrekar, K. D., Goyal, A., Mahadevan, A., Anandan, E. M., Sankaran, M. T., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120633 · Cited by 7
Uchewa, O. O., Alobu, E. J., Favour, I. C., Jennifer, U. C., Chinwendu, J. C., Maria-Goretti, I. C., Favour, I. C., Chikwado, I. P., Precious, I. N., Chukwuemeka, I., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.10.015 · Cited by 5
Xu, Y., Peng, Y., Zhi, F., Yang, Y., Li, J., Fan, L., Xia, Y., & Shao, N. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106149 · Cited by 4
Fu, Y., Zhang, X., Li, L., Jiang, H., Ren, Q., Yi, T., Zhang, Y., & Lu, Y. (2025) · Antioxidants · doi:10.3390/antiox14111321 · Cited by 6
“Under lipid overload stimulation, microglia release large amounts of pro-inflammatory factors, forming a chronic neuroinflammatory microenvironment [63].”
Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease
Ward, K., Cole, M. H., Griffiths, L. R., Sutherland, H. G. E., Winberg, P. C., Meyer, B. J., & Fernandez, F. (2025) · Molecules · doi:10.3390/molecules30224456 · Cited by 4
“These phenotypic changes coincide with synaptic loss and tau hyperphosphorylation, hallmarks of cognitive decline in AD [124], suggesting that microglial dysfunction contributes to sustained neuroinflammation and neuronal degeneration.”
Dynamic astrocytic complement C3 activation in the epileptic hippocampus
Jiang, M., Romagnolo, A., Aronica, E., & Wang, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1682488 · Cited by 3
Guglielmo, S., Nardo, N. D., Scantamburlo, M., Mainardi, M., van den Oever, M. C., & Origlia, N. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70953 · Cited by 3
“Indeed, reactive astrocytes and microglia are detectable in the hippocampus by 2 to 3 months of age 44 ; moreover, microglial signaling has been impli-catedincomplement-dependentsynapseloss 45 andRAGE-p38MAPK-mediated plasticity deficits in the EC.”
Zhou, Z., Deng, Z., Huang, Y., Chen, J., Yang, J. H., & Cao, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116636 · Cited by 4
Ali, S., Johnson, A. O., Villanueva, M., Im, E. Y., Justice, J. M., Chapurin, N., Lobo, B. C., Mulligan, J. K., & Atkinson, C. (2025) · Chemical Senses · doi:10.1093/chemse/bjaf061 · Cited by 3
Yang, C., Li, B., Yang, S. ‐., Wang, X., Zhu, G., & Wang, J. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70696 · Cited by 2
“Our results also confirmed that APP/PS1 mice exhibited AD-like phenotypes including neuroinflammation and synaptic deficits, which were highly consistent with early symptoms of clinical AD patients [33].”
Burrell, P. E., Fleenor, D. E., Nicholson, O. M., Shao, C., & Kastan, M. B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2518589122 · Cited by 2
“However, overactivation of microglia can lead to the nonselective, uncontrolled phagocytosis of live neurons and synapses; such pathology has been observed in mouse models of Alzheimer’s Disease ( 66 , 87 , 97 ).”
Redox Regulation of Complement Pathway Activation in Aging and Related Diseases
Ferdowsi, S., Arjuna, S., Sudharshan, S. J., & Zennadi, R. (2025) · Antioxidants · doi:10.3390/antiox15010029 · Cited by 3
“Biochemical assays demonstrate that fibrillar A β and aggregated tau activate the classical and alternative pathways, driving local deposition of C1q, C3, and the MAC in parenchymal plaques [222,233].”
The Cerebral Clearance Cascade as a Driver of Alzheimer’s Disease Progression
Izrael, M., & Frenkel, O. M. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3010001 · Cited by 2
“However, chronic exposure to aggregated proteins and inflammatory signals can trigger microglial exhaustion, characterized by reduced phagocytic capacity, lysosomal dysfunction, and switch to a pro-inflammatory secretory profile that amplifies rather than resolves pathology [59].”
Dalakas, M. C., & Späth, P. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00014-6 · Cited by 3
Zhang, X., Yu, Z., Hao, G., Yao, Q., Hu, Y., Wang, F., Chen, X., Liu, L., Wong, K., & Li, X. (2026) · Nature Communications · doi:10.1038/s41467-026-68500-6 · Cited by 5
“Previous studies have reported that these genes are highly expressed in A β -associated microglia, where they are involvedinmediatingsynapticlossinAlzheimer ’ sdisease 60 .”
Mackie, P. M., Koshy, J. M., Bhogade, M., Hammoor, T., Hachmeister, W., Lloyd, G. M., Paterno, G., Bolen, M. L., Merchak, A. R., Tansey, M. G., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68641-8 · Cited by 12
“Prominent examples include activating the adaptive immune response, which can lead to neuronal death 34 – 36 , and microglia-mediated complement-dependent synaptic pruning 37 – 40 , which mechanistically links protein aggregates to neuronal dysfunction.”
Xue, D. Q., Hu, X., Li, R., Sun, T., Qian, S., Chu, F., Huawu, G., Li, F., & Cai, B. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157919 · Cited by 6
Zhao, P., Li, S., Liu, Q., Peng, X.-C., Liu, L., Yang, F.-Y., Wang, C., Qian, F., & Tang, F.-R. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1726194 · Cited by 7
Self-citationThe Role of Cold-Inducible RNA-Binding Protein (CIRP) in Neurological Disorders
Lai, X., & Zhong, P. (2026) · Brain Sciences · doi:10.3390/brainsci16020205 · Cited by 2
“…in maintaining the blood–brain barrier [113,114], as well as the interactions between astrocytes and microglia under pathological conditions [115,116], it is speculated that eCIRP may further exacerbate blood–brain barrier disruption and neuronal injury during the pathological progression of IS…”
Rao, N. R., Santiago-Marrero, I. G., DeGulis, O. A., Nomura, T., Goyal, K., Lee, S., Hark, T. J., Dynes, J. C., Dexter, E., Dulewicz, M., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adp3984 · Cited by 7
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.